What are the signs and symptoms of Systemic Lupus Erythematosus (SLE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus is a multisystem autoimmune disease primarily affecting women of reproductive age, characterized by cutaneous, musculoskeletal, renal, neurologic, hematological, and pulmonary manifestations that can lead to significant morbidity and mortality. 1

Common Clinical Manifestations

Constitutional Symptoms

  • Fatigue (very common)
  • Fever
  • Weight loss

Mucocutaneous Manifestations

  • Malar (butterfly) rash
  • Discoid rash
  • Photosensitivity
  • Oral ulcers
  • Alopecia
  • Raynaud's phenomenon

Musculoskeletal Manifestations

  • Arthritis (non-erosive)
  • Arthralgia
  • Myalgia
  • Morning stiffness

Renal Manifestations

  • Proteinuria
  • Hematuria
  • Cellular casts
  • Elevated creatinine

Neuropsychiatric Manifestations

  • Seizures (common, >5% cumulative incidence) 1
  • Cerebrovascular disease (common, >5% cumulative incidence) 1
  • Cognitive dysfunction (1-5% for severe form) 1
  • Acute confusional state (1-5%) 1
  • Psychosis (1-5%) 1
  • Major depression (1-5%) 1
  • Headache

Hematologic Manifestations

  • Anemia (hemolytic or chronic disease)
  • Leukopenia
  • Lymphopenia
  • Thrombocytopenia

Pulmonary Manifestations

  • Pleural effusion (most common pulmonary manifestation) 1
  • Dyspnea
  • Chest pain
  • Reduced exercise tolerance
  • Cough
  • Hemoptysis
  • Interstitial lung disease (1-15% of patients) 1

Cardiovascular Manifestations

  • Pericarditis
  • Myocarditis
  • Libman-Sacks endocarditis
  • Accelerated atherosclerosis

Laboratory Findings

Immunologic Markers

  • Positive ANA (>90% of patients) 2
  • Anti-dsDNA antibodies
  • Anti-Sm antibodies
  • Low complement levels (C3, C4)
  • Antiphospholipid antibodies (associated with cerebrovascular disease, seizures, and chorea) 1
  • Anti-La/SSB, anti-Scl-70, and anti-U1RNP antibodies (associated with ILD development) 1

Other Laboratory Abnormalities

  • Elevated inflammatory markers (ESR, CRP)
  • Cytopenias (anemia, leukopenia, thrombocytopenia)
  • Proteinuria/abnormal urinalysis

Disease Patterns and Timing

  • Most neuropsychiatric events (50-60%) occur at disease onset or within the first year after SLE onset 1
  • Between 20-90% of patients will develop respiratory involvement during the course of their disease 1
  • About 40% of people with SLE develop lupus nephritis 3

Risk Factors for Specific Manifestations

For Interstitial Lung Disease

  • Male gender
  • Older age
  • Advanced disease stage
  • Previous episodes of acute lupus pneumonitis
  • Raynaud phenomenon
  • Gastroesophageal reflux disease
  • Tachypnea
  • Abnormal nail-fold capillaries
  • Elevated CRP
  • Anti-Sm and anti-U1-RNP seropositivity 1

For Neuropsychiatric Manifestations

  • General SLE activity or damage
  • Previous neuropsychiatric events
  • Concurrent NPSLE manifestations
  • Antiphospholipid antibodies 1

Clinical Pearls

  • SLE symptoms often wax and wane, with periods of flares and remission 2
  • Early manifestations typically include constitutional symptoms, mucocutaneous findings, and musculoskeletal complaints 4
  • Diagnosis can be challenging as SLE mimics many other diseases 5
  • The 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology classification criteria are 96.1% sensitive and 93.4% specific for SLE 3

Early recognition of these signs and symptoms is crucial for timely diagnosis and management to prevent organ damage and improve patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Systemic lupus erythematosus.

Orphanet journal of rare diseases, 2006

Research

Systemic lupus erythematosus.

Lancet (London, England), 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.